Byonyks Email Format
Medical Equipment ManufacturingIllinois, United States51-200 Employees
Byonyks develops a peritoneal dialysis system that has obtained FDA clearance. The device is designed to be portable, non-invasive, and needle-free, enabling patients to perform dialysis at home overnight. This approach aims to lower infection risks and reduce costs relative to traditional dialysis options. The technology targets individuals with kidney failure who lack reliable access to dialysis globally, helping them maintain work and family routines through home-based therapy. Headquartered in the Chicago area, Itasca, Illinois, the company was founded by Harvard and MIT graduates and other industry experts, a leadership team that has contributed to a substantial share of operational peritoneal dialysis machines in the United States. In June 2026, Byonyks announced FDA 510(k) clearance for its X1 Automated Peritoneal Dialysis Cycler, a notable regulatory milestone for expanding access to home dialysis.